
Agomab Therapeutics approves all AGM agenda items, including board reappointments and financials.
Agomab Therapeutics NV held its Annual General Meeting on May 26, 2026, where shareholders approved all agenda items. This included the approval of the 2025 financial statements, discharge of board members and auditors for their duties, and the reapp...


